Key takeaways
- Both are prescription semaglutide products, but each has its own FDA-approved labeling.
- Wegovy is commonly discussed for chronic weight management, while Ozempic is commonly discussed for type 2 diabetes.
- They should not be combined or substituted without a prescriber and pharmacist reviewing the complete situation.
How they compare
EDITORIAL GUIDETopicWegovysemaglutideOzempicsemaglutide
Active ingredientSemaglutideSemaglutide
Medication classGLP-1 receptor agonistGLP-1 receptor agonist
Common FDA-approved focusChronic weight management for eligible patientsType 2 diabetes management for eligible patients
AccessPrescription requiredPrescription required
DecisionEligibility, risks, current medicines, and goals must be reviewedDiabetes history, risks, current medicines, and goals must be reviewed
Primary sources
Labeling can change. Use the current FDA prescribing information and speak with a licensed clinician or pharmacist before making a treatment decision.